Related references
Note: Only part of the references are listed.Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations
Anthony Letai et al.
CANCER CELL (2022)
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study
Florence Joly et al.
GYNECOLOGIC ONCOLOGY (2022)
Venetoclax in Previously Treated Waldenstrom Macroglobulinemia
Jorge J. Castillo et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis
Rongqing Pan et al.
CELL (2022)
Physiological and pharmacological modulation of BAX
Adam Z. Spitz et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer
Andrea Lopez et al.
NATURE COMMUNICATIONS (2022)
Adapted to Survive: Targeting Cancer Cells with BH3 Mimetics
Joan Montero et al.
CANCER DISCOVERY (2022)
Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells
Elizabeth J. Osterlund et al.
SCIENCE ADVANCES (2022)
A Mesenchymal Tumor Cell State Confers Increased Dependency on the BCL-XL Antiapoptotic Protein in Kidney Cancer
Treg Grubb et al.
CLINICAL CANCER RESEARCH (2022)
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics
Cameron S. Fraser et al.
NATURE COMMUNICATIONS (2022)
Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade
Frederick J. Kohlhapp et al.
CANCER DISCOVERY (2021)
Oncogenic Mechanisms and Therapeutic Targeting of Metabolism in Leukemia and Lymphoma
Maximilian Stahl et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)
Targeting MCL-1 in cancer: current status and perspectives
Haolan Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics
Veerle W. Daniels et al.
SCIENCE SIGNALING (2021)
BH3 profiling discriminates on-target small molecule BH3 mimetics from putative mimetics
Mariana Villalobos-Ortiz et al.
CELL DEATH AND DIFFERENTIATION (2020)
The cell biology of mitochondrial membrane dynamics
Marta Giacomello et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Overcoming MCL-1-driven adaptive resistance to targeted therapies
Kris C. Wood
NATURE COMMUNICATIONS (2020)
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
Shanshan Pei et al.
CANCER DISCOVERY (2020)
Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer
Kevin H. Lin et al.
NATURE GENETICS (2020)
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling
Chuanhui Han et al.
NATURE IMMUNOLOGY (2020)
Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells
Courtney L. Jones et al.
CELL STEM CELL (2020)
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
C. D. DiNardo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
Shaji K. Kumar et al.
LANCET ONCOLOGY (2020)
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells
Brett M. Stevens et al.
NATURE CANCER (2020)
Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity
Kevin H. Lin et al.
CELL METABOLISM (2019)
Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
Xufeng Chen et al.
CANCER DISCOVERY (2019)
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
Romain Guieze et al.
CANCER CELL (2019)
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer
Elizabeth H. Stover et al.
MOLECULAR CANCER RESEARCH (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan et al.
NATURE MEDICINE (2019)
Targeting the Bcl-2 Family in B Cell Lymphoma
Clare M. Adams et al.
FRONTIERS IN ONCOLOGY (2019)
Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors
Margaret B. Pulsifer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina et al.
NATURE MEDICINE (2018)
Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors
Grace R. Anderson et al.
NATURE COMMUNICATIONS (2018)
Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity
Ryan S. Soderquist et al.
NATURE COMMUNICATIONS (2018)
Exploiting MCL1 Dependency with Combination MEK+MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non-Small Cell Lung Cancer
Varuna Nangia et al.
CANCER DISCOVERY (2018)
Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
Kyung-A Song et al.
CLINICAL CANCER RESEARCH (2018)
Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency
Evangelos Giampazolias et al.
NATURE CELL BIOLOGY (2017)
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Elodie M. Kuntz et al.
NATURE MEDICINE (2017)
Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence
Katherine R. Singleton et al.
CELL REPORTS (2017)
Developmental Regulation of Mitochondria! Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics
Kristopher A. Sarosiek et al.
CANCER CELL (2017)
Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing
Andrew L. Paek et al.
CELL (2016)
Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane
Katelyn L. O'Neill et al.
GENES & DEVELOPMENT (2016)
Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors
Lisa S. Kahalley et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Andras Kotschy et al.
NATURE (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation
Grace R. Anderson et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
Mohammed Najim Abed et al.
JOURNAL OF OVARIAN RESEARCH (2016)
A fate worse than death: apoptosis as an oncogenic process
Gabriel Ichim et al.
NATURE REVIEWS CANCER (2016)
Mitochondrial apoptosis: killing cancer using the enemy within
J. Lopez et al.
BRITISH JOURNAL OF CANCER (2015)
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
Joan Montero et al.
CELL (2015)
Mitochondrial Shape Governs BAX-Induced Membrane Permeabilization and Apoptosis
Thibaud T. Renault et al.
MOLECULAR CELL (2015)
Limited Mitochondrial Permeabilization Causes DNA Damage and Genomic Instability in the Absence of Cell Death
Gabriel Ichim et al.
MOLECULAR CELL (2015)
Mitochondrial Division Is Requisite to RAS-Induced Transformation and Targeted by Oncogenic MAPK Pathway Inhibitors
Madhavika N. Serasinghe et al.
MOLECULAR CELL (2015)
Erk2 Phosphorylation of Drp1 Promotes Mitochondrial Fission and MAPK-Driven Tumor Growth
Jennifer A. Kashatus et al.
MOLECULAR CELL (2015)
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
Michael J. White et al.
CELL (2014)
Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA
Anthony Rongvaux et al.
CELL (2014)
Programmed cell death during neuronal development: the sympathetic neuron model
M. Kristiansen et al.
CELL DEATH AND DIFFERENTIATION (2014)
Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis
Toru Okamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199
Triona Ni Chonghaile et al.
CANCER DISCOVERY (2014)
Molecular Pathogenesis of Follicular Lymphoma
Wataru Kishimoto et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2014)
Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Francois Vaillant et al.
CANCER CELL (2013)
Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
Ryan B. Corcoran et al.
CANCER CELL (2013)
Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction
Xi Wang et al.
GENES & DEVELOPMENT (2013)
BID Preferentially Activates BAK while BIM Preferentially Activates BAX, Affecting Chemotherapy Response
Kristopher A. Sarosiek et al.
MOLECULAR CELL (2013)
Mcl-1 is essential for the survival of plasma cells
Victor Peperzak et al.
NATURE IMMUNOLOGY (2013)
Apoptosis therapy: driving cancers down the road to ruin
Douglas R. Green et al.
NATURE MEDICINE (2013)
Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation
Jianjian Shi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Sphingolipid Metabolism Cooperates with BAK and BAX to Promote the Mitochondrial Pathway of Apoptosis
Jerry E. Chipuk et al.
CELL (2012)
NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1
A. Craxton et al.
CELL DEATH AND DIFFERENTIATION (2012)
Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
Charles M. Rudin et al.
CLINICAL CANCER RESEARCH (2012)
Bim: Guardian of Tissue Homeostasis and Critical Regulator of the Immune System, Tumorigenesis and Bone Biology
Toru Akiyama et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2011)
Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells
Alejo A. Morales et al.
BLOOD (2011)
Programmed Cell Death in Animal Development and Disease
Yaron Fuchs et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Role of ERK-BIM and STAT3-Survivin Signaling Pathways in ALK Inhibitor-Induced Apoptosis in EML4-ALK-Positive Lung Cancer
Ken Takezawa et al.
CLINICAL CANCER RESEARCH (2011)
Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential
Ying-bei Chen et al.
JOURNAL OF CELL BIOLOGY (2011)
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
Leena Gandhi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1F0 ATP synthase
Kambiz N. Alavian et al.
NATURE CELL BIOLOGY (2011)
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Triona Ni Chonghaile et al.
SCIENCE (2011)
BIM Expression in Treatment-Naive Cancers Predicts Responsiveness to Kinase Inhibitors
Anthony C. Faber et al.
CANCER DISCOVERY (2011)
Apoptosis Threshold Set by Noxa and Mcl-1 after T Cell Activation Regulates Competitive Selection of High-Affinity Clones
Felix M. Wensveen et al.
IMMUNITY (2010)
The Proapoptotic Function of Noxa in Human Leukemia Cells Is Regulated by the Kinase Cdk5 and by Glucose
Xazmin H. Lowman et al.
MOLECULAR CELL (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
βTrCP- and Rsk1/2-Mediated Degradation of BimEL Inhibits Apoptosis
Elinor Dehan et al.
MOLECULAR CELL (2009)
Regulation of Bcl-2 Family Proteins by Posttranslational Modifications
Anthony Letai et al.
CURRENT MOLECULAR MEDICINE (2008)
Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization
Ryuji Yamaguchi et al.
MOLECULAR CELL (2008)
Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c
Allyson E. Vaughn et al.
NATURE CELL BIOLOGY (2008)
Dual role of proapoptotic BAD in insulin secretion and beta cell survival
Nika N. Danial et al.
NATURE MEDICINE (2008)
Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM
J. A. Wickenden et al.
ONCOGENE (2008)
Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion
Jing Deng et al.
CANCER RESEARCH (2007)
Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas
Yixuan Gong et al.
PLOS MEDICINE (2007)
BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations
Daniel B. Costa et al.
PLOS MEDICINE (2007)
Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics
Mark S. Cragg et al.
PLOS MEDICINE (2007)
Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1
Yu Fang Wang et al.
CLINICAL CANCER RESEARCH (2007)
Programmed anuclear cell death delimits platelet life span
Kylie D. Mason et al.
CELL (2007)
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
Victoria Del Gaizo Moore et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion
Christian Frezza et al.
CELL (2006)
FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal
Han You et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Proapoptotic BID is an ATM effector in the DNA-damage response
I Kamer et al.
CELL (2005)
A role for proapoptotic BID in the DNA-damage response
SS Zinkel et al.
CELL (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma
WL Zhao et al.
BLOOD (2004)
p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa
A Villunger et al.
SCIENCE (2003)
Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function
F Luciano et al.
ONCOGENE (2003)
Postnatal brain development and neural cell differentiation modulate mitochondrial Bax and BH3 peptide-induced cytochrome c release
BM Polster et al.
CELL DEATH AND DIFFERENTIATION (2003)
PUMA mediates the apoptotic response to p53 in colorectal cancer cells
J Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
BID regulation by p53 contributes to chemosensitivity
JK Sax et al.
NATURE CELL BIOLOGY (2002)
Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells
C von Haefen et al.
ONCOGENE (2002)
Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
MC Wei et al.
SCIENCE (2001)
PUMA induces the rapid apoptosis of colorectal cancer cells
J Yu et al.
MOLECULAR CELL (2001)
Effect of ionizing radiation on the human brain: White matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy
RG Steen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Share Paper
